ArticleClinicoEconomics and outcomes research : CEOR2018

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes.

E J Gibson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.